
[TimAlerts] RXDX - "FDA OKs the use of Ignyta's investigational next-gen sequencing assay as a companion diagnostic in mid-stage study of entrectinib; shares up 4% premarket" - http://finance.yahoo.com/news/ignyta-announces-approval-investigational-device-110000805.html



